Subsidy Information and Financing Scheme SDLUmeclidinium Inhalation Powder 62.5 mcg/dose (30 inhalations)
Drug Guidance for Subsidy 02/07/2018 LAMA & LAMA/LABA for chronic obstructive pulmonary disease (COPD) The Ministry of Health’s Drug Advisory Committee has recommended: Umeclidinium 62.5mcg inhal... See all × 02/07/2018 LAMA & LAMA/LABA for chronic obstructive pulmonary disease (COPD) The Ministry of Health’s Drug Advisory Committee has recommended: Umeclidinium 62.5mcg inhalation powder for the: Maintenance treatment of patients diagnosed by spirometry with chronic obstructive pulmonary disease (Group B or C) who have breathlessness. Umeclidinium/vilanterol 62.5/25mcg inhalation powder for the: Maintenance treatment of patients diagnosed by spirometry with chronic obstructive pulmonary disease (Group B or C) who have frequent exacerbations (at least 2 per year or at least 1 leading to hospitalisation per year) and/or persistent breathlessness despite treatment with LAMA monotherapy. Maintenance treatment of patients diagnosed by spirometry with chronic obstructive pulmonary disease (Group D) with persistent symptoms and frequent exacerbations. Subsidy status RUmeclidinium 62.5mcg inhalation powder and umeclidinium/vilanterol 62.5/25mcg inhalation powder are recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indications. NRSDL subsidies do not apply to the following: Other LAMAs (glycopyrronium, tiotropium or aclidinium) Other LAMA/LABAs (indacaterol/glycopyrronium, tiotropium/olodaterol or aclidinium/formoterol)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Inhalation Powder 62.5 mcg/dose (30 inhalations) Alexandra Hospital Changi General Hospital Institute of Mental Health Khoo Teck Puat Hospital National Cancer Centre National Healthcare Group Polyclinics Ng Teng Fong General Hospital National University Hospital National University Polyclinics Sengkang General Hospital Singapore General Hospital SingHealth Polyclinics Tan Tock Seng Hospital Woodlands Health Campus
RESPIRATORY (INHALATION) Select a brand starting with the letter: I INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE [SIN14853P]